Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mutation of TGFβ-RII eliminates NSAID cancer chemoprevention.

Oncotarget·2018
Same author

Loss of miR-204 expression is a key event in melanoma.

Molecular cancer·2018
Same author

Retraction for Melillo et al., "Critical Role of the HMGI(Y) Proteins in Adipocytic Cell Growth and Differentiation".

Molecular and cellular biology·2018
Same author

Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia.

Oncotarget·2018
Same author

Long noncoding RNAs: Undeciphered cellular codes encrypting keys of colorectal cancer pathogenesis.

Cancer letters·2018
Same author

The role of MicroRNAs in human cancer.

Signal transduction and targeted therapy·2017

Related Experiment Video

Updated: Jun 8, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Molecular basis of CLL.

Yuri Pekarsky1, Nicola Zanesi, Carlo M Croce

  • 1Human Cancer Genetics Program and Department of Molecular Virology, Immunology and Medical Genetics, OSU School of Medicine, Ohio State University, Columbus, OH 43210, USA. Pekarsky.Yuri@osumc.edu

Seminars in Cancer Biology
|September 25, 2010
PubMed
Summary

B-cell chronic lymphocytic leukemia (CLL) involves specific B-lymphocyte expansion. New research clarifies molecular pathways and utilizes mouse models to understand aggressive and indolent CLL development.

More Related Videos

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

Related Experiment Videos

Last Updated: Jun 8, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • B-cell chronic lymphocytic leukemia (CLL) is the most common leukemia in Western countries.
  • CLL arises from CD5+ mature B-lymphocyte expansion, presenting as aggressive or indolent forms.
  • Distinctive molecular markers, including ZAP-70 expression and IgH V(H) mutation status, differentiate CLL subtypes.

Purpose of the Study:

  • To elucidate the emerging molecular mechanisms driving CLL development.
  • To review recent insights into tumor suppressor and oncogene pathways in CLL.
  • To discuss the utility of mouse models in recapitulating CLL molecular pathogenesis.

Main Methods:

  • Review of recent scientific literature on CLL molecular pathways.
  • Analysis of findings related to microRNAs (e.g., miR-15/16) and oncogenes (e.g., TCL1).
  • Evaluation of data from various mouse models of CLL.

Main Results:

  • MiR-15/16 and DLEU7 act as tumor suppressors at the 13q14 locus, implicated in indolent CLL.
  • Activation of the oncogene TCL1 is crucial for the initiation of aggressive CLL.
  • Mouse models have provided valuable support for understanding these molecular pathways.

Conclusions:

  • Significant progress has been made in understanding the molecular underpinnings of CLL.
  • Specific pathways involving tumor suppressors and oncogenes are critical in CLL pathogenesis.
  • Mouse models are essential tools for investigating CLL and validating molecular findings.